Surveillance for infectious complications in pediatric acute liver failure - a prospective study
Suresh Mekala1, Barath Jagadisan, Subhash Chandra Parija
1Department of Pediatrics, Jawaharlal Institute of Postgraduate Medical Education and Research, Dhanvantri Nagar, Pondicherry, 605006, India.
Insights
Infectious complications (IC) are common in pediatric acute liver failure (PALF), often occurring after admission despite antibiotic use. These infections prolong hospital stays but do not increase mortality.
Area of Science:
- Pediatric critical care medicine
- Hepatology
- Infectious diseases
Background:
- Pediatric acute liver failure (PALF) is a life-threatening condition.
- Infectious complications (IC) are a significant concern in PALF patients.
- Surveillance cultures are crucial for early detection of IC.
Purpose of the Study:
- To prospectively evaluate the incidence and characteristics of IC in pediatric acute liver failure (PALF).
- To assess the impact of IC on patient outcomes, including mortality and length of stay.
- To guide empirical treatment strategies for infections in PALF.
Main Methods:
- Prospective evaluation of 29 children with PALF over two years.
- Standardized management protocol including prophylactic parenteral antibiotics.
- Surveillance cultures of blood, urine, ascites, and tracheal aspirates were performed.
Main Results:
- Bloodstream infections (BSI) were present in 13.8% of patients at admission.
- Gram-negative bacteria, fungi (Candida non-albicans), and Gram-positive bacteria were identified.
- IC prolonged pediatric intensive care unit (PICU) and hospital stay but did not increase mortality.
Conclusions:
- BSI is a frequent finding at PALF admission.
- Breakthrough Gram-negative bacterial and fungal ICs are common despite prophylactic antibiotics.
- Empirical treatment should be broad-spectrum, and prophylactic antifungals may be considered.
Objective:
To prospectively evaluate infectious complications (IC) in pediatric acute liver failure (PALF) by employing surveillance cultures.
Methods:
From 2011 to 2013, children with PALF in a tertiary care centre received a standard protocolised management. Prophylactic parenteral antibiotics were used without antifungals. Surveillance cultures of blood, urine, ascites and tracheal aspirates were sent. Biochemical and clinical parameters and outcomes were compared between children with and without IC.
Results:
Of the 29 children with PALF admitted during the study period (median age 36 mo, range 12-90 mo), 13.8 % had blood stream infections (BSI) at admission. Organisms were isolated in 8.8 % (12/136) of the blood cultures, 13.7 % (11/80) of the urine cultures, 30.8 % (8/26) of the tracheal aspirates and 7.1 % (1/14) of the ascitic fluid cultures. Gram negative bacteriae (n = 17) were the commonest, followed by fungi (n = 13) and gram positive bacteriae (n = 2). Klebsiella pneumoniae and Candida nonalbicans group were the commonest bacteria and fungi respectively. After admission, fungal BSI and urinary tract infections were diagnosed at a median time of 4 d (range 3-8 d) and 3.5 d (range 3-6 d) respectively. ICs were not associated with other complications and increased mortality but with longer hospital and pediatric intensive care unit (PICU) stay.
Conclusions:
In this study BSI was a common finding at admission in PALF. Inspite of prophylactic antibiotics, break through gram negative bacterial and fungal ICs were common. Empirical treatment of IC should include broad spectrum antibiotics. Fungal IC occurred beyond 48 h. Prophylactic antifungals at admission may be considered to decrease their frequency. IC prolongs PICU and hospital stay.
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Pharmacokinetics in Pediatric Patients: Drug Excretion
Acute Kidney Injury VI: Nursing Management
Acute Kidney Injury I: Introduction


